
Arjun Mohan
@arjun_mohan1
Nephrology Fellow at Mayo Clinic Rochester | NSMC 2023 |
ID: 1359182594328432642
09-02-2021 16:49:29
79 Tweet
297 Followers
1,1K Following


Efficacy and Safety of #Rituximab in Antiglomerular Basement Membrane Disease #AntiGBM #VisualAbstract by Arjun Mohan kireports.org/article/S2468-β¦


Incidence of Acute Kidney Injury in Relapsed and Refractory Multiple Myeloma treated with Teclistamab versus CAR T-cells. #MayoClinicKidney Mariam Charkviani Elena-Bianca Barbir, MD Arjun Mohan maria jose vargas Yi Lin Sandra Herrmann MD, FASN NDT pubmed.ncbi.nlm.nih.gov/39805729/


Excited to share our study on incidence of AKI with Teclistamab vs CAR-T therapy in treatment-resistant multiple myeloma. The first to evaluate this important relationship! pubmed.ncbi.nlm.nih.gov/39805729/ Sandra Herrmann MD, FASN Yi Lin Arjun Mohan Mayo Clinic Nephrology NDT


Excited to attend to #ISNWCN 2025. Looking forward to all the learning and fun!! Mayo Clinic Nephrology


Proud of our Mayo Clinic Nephrology fellows for representing our division at the World Congress of Nephrology/WCN 2025 in New Delhi! Excited to see their contributions on the global stage. #ISNWCN 2025 πβΊοΈ Naim Issa Jose Arriola-Montenegro Arjun Mohan World Congress of Nephrology Int Society of Nephrology


Thanks π World Congress of Nephrology for wonderful meetings #ISNWCN 2025 Great opportunities for our Mayo Clinic Nephrology fellows for representing our division at the World Congress of Nephrology/WCN 2025 in New Delhi! Naim Issa Jose Arriola-Montenegro Arjun Mohan World Congress of Nephrology Int Society of Nephrology


ππ½In patients with cancer CKD-EPIcrCys and EKFC crCys equations presented better performance compared to mGFR than the Cr or Cystatin C only! Time to advocate for combined CrCys eGFR in patients with cancer! ASN Publications American Society of Onconephrology ASCO

tandfonline.com/doi/full/10.10β¦ Public interest in chronic kidney disease and dialysis Jose Arriola-Montenegro Jing ^_^ Wisit Cheungpasitporn MD FACP | FASN | FAST Jose Arriola-Montenegro, Wisit Cheungpasitporn, Charat Thongprayoon, Iasmina M. Craici & Jing Miao Renal Failure T&F Medicine & Healthcare #DigitalHealth #Neprology

Excited to share our latest review on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and its renal & cardiac implications! #CHIP #Nephrology Check out the tweetorial below! π NDT @bwhkidney Mayo Clinic Nephrology HofNorthwell Kidney Full Manuscript:

Don't miss this Mayo Clinic Nephrology conference! Onco-Nephrology Symposium will cover nephrotoxicity of chemotherapeutic agents, patients with dialysis-dependent end-stage renal disease, & much more. Register for Sept. 11-12 in Minnesota & via livestream. mayocl.in/4j3nYqg


Excited to share our new review on hypertension in advanced CKD & dialysisβcovering updated KDIGO targets & emerging therapies. Grateful to Leticia Rolon , M. Lourdes GonzΓ‘lez SuΓ‘rez, and Mayo Clinic Nephrology for their guidance and support! pubmed.ncbi.nlm.nih.gov/40183393/

πππ» Thank you so much for the love and support. Iβm deeply grateful to receive the 2025 #Teacher of the Year award in Nephrology. #MedEd Mayo Clinic Mayo Clinic Nephrology Thank You so much for your support tonight M. Lourdes GonzΓ‘lez SuΓ‘rez Oscar Garcia, MD



The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy - Kidney International Nattawat Klomjit β¦fernando fervenzaβ© β¦Sanjeev Sethiβ© kidney-international.org/article/S0085-β¦

π£π’ βππ«π¬π πππ²π¨ ππ₯π’π§π’π - πππ₯π₯ πβππππ«π¨π§ ππππππππππ ππππππβ save the dates 5-6 Sep Barcelona 2025. Register to [email protected] organized by Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza


We are glad to release ASON monthly news letter highlighting the most recent and important work in the field of onconephrology News letter curated by Maulin Patel Bryce C Arjun Mohan Pooja Amarapurkar Sabine Karam Swetha Kanduri ason-online.org/so/19PV1hcB1?lβ¦

Onco-Nephrology Symposium on September 11-12, 2025. Please join us for this exciting event ( In- person  or virtually). Register here: ce.mayo.edu/nephrology/con⦠Sandra Herrmann MD, FASN M. Lourdes GonzÑlez SuÑrez Leticia Rolon

Membranous nephropathy has undergone a paradigm shift due to the discovery of unique MN antigens. MN has gone from idiopathic to β‘οΈ primary vs. secondary β‘οΈ where an antigen can be detected in ~80% of MN. This is a comprehensive review of each antigen. nature.com/articles/s4158β¦

I am excited to share our latest paper on the potential association between monoclonal gammopathy and ANCA negative vasculitis. Monoclonal testing should be considered in ANCA negative patients. maria jose vargas fernando fervenza journals.lww.com/kidney360/abstβ¦